Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
KORU Medical Systems, Inc. reported the fourth quarter and year ended December 31, 2023 results: revenue $28.5 million, net income ($13.7) million, or ($0.30) per share.
- Period
- the fourth quarter and year ended December 31, 2023
- Revenue
- $28.5 million
- Net income
- ($13.7) million, or ($0.30) per share
- Result
- reported results
Exact text from the filing
issued guidance for the full year 2024. Recent Highlights ● Fourth quarter 2023 net revenues of $7.2 million, a 2% decrease from the prior year; Full year 2023 net revenues of $28.5 million, a 2% increase over the prior year ● Full year 6.7% Core business growth (U.S. and International) driven by overall SCIg market growth, share gains and expansion in new
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
KORU Medical Systems, Inc. entered into Loan and Security Agreement with HSBC Ventures USA Inc. valued at $5,000,000 (effective 2024-03-08).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- HSBC Ventures USA Inc.
- Value
- $5,000,000
- Effective
- 2024-03-08
Exact text from the filing
On March 8, 2024, KORU Medical Systems, Inc. (the “Company”) entered into a loan and security agreement (the “Loan and Security Agreement”), by and between the Company and HSBC Ventures USA Inc., as lender providing for a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the “Revolver”) and a term loan facility in an aggregate principal amount not to exceed $5,000,000
View on SEC.gov